tradingkey.logo
tradingkey.logo
検索

Merck & Co Inc

MRK
ウォッチリストに追加
111.380USD
-0.920-0.82%
終値 05/08, 16:00ET15分遅れの株価
275.09B時価総額
31.22直近12ヶ月PER

Merck & Co Inc

111.380
-0.920-0.82%

詳細情報 Merck & Co Inc 企業名

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Merck & Co Incの企業情報

企業コードMRK
会社名Merck & Co Inc
上場日Feb 06, 2077
最高経営責任者「CEO」Davis (Robert M)
従業員数75000
証券種類Ordinary Share
決算期末Feb 06
本社所在地126 East Lincoln Avenue
都市RAHWAY
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号07065
電話番号19087404000
ウェブサイトhttps://www.merck.com/
企業コードMRK
上場日Feb 06, 2077
最高経営責任者「CEO」Davis (Robert M)

Merck & Co Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
443.60K
-10.69%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
199.21K
--
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
92.03K
-8.72%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
68.92K
+5.68%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
55.21K
-72.45%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+19.93%
Ms. Patricia F. Russo
Ms. Patricia F. Russo
Independent Director
Independent Director
13.15K
--
Mr. Thomas Henry (Tom) Glocer, J.D.
Mr. Thomas Henry (Tom) Glocer, J.D.
Lead Independent Director
Lead Independent Director
5.10K
--
Mr. Inge G. Thulin
Mr. Inge G. Thulin
Independent Director
Independent Director
2.93K
--
Ms. Pamela J. Craig
Ms. Pamela J. Craig
Independent Director
Independent Director
1.72K
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
443.60K
-10.69%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
199.21K
--
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
92.03K
-8.72%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
68.92K
+5.68%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
55.21K
-72.45%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+19.93%

収益内訳

通貨: USD更新時刻: Mon, Apr 6
通貨: USD更新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Oncology-Keytruda
31.64B
48.67%
Vaccines -Gardasil/Gardasil
5.23B
8.05%
Animal Health-Livestock
3.90B
5.99%
Other pharmaceutical
2.92B
4.49%
Animal Health-Companion Animals
2.46B
3.78%
他の
18.86B
29.02%
地域別USD
会社名
収益
比率
United States
36.51B
56.16%
Europe, Middle East and Africa
14.58B
22.43%
Latin America
3.41B
5.25%
Asia Pacific (Other than China and Japan)
2.98B
4.59%
Other
2.88B
4.43%
他の
4.65B
7.15%
事業別
地域別
事業別USD
会社名
収益
比率
Oncology-Keytruda
31.64B
48.67%
Vaccines -Gardasil/Gardasil
5.23B
8.05%
Animal Health-Livestock
3.90B
5.99%
Other pharmaceutical
2.92B
4.49%
Animal Health-Companion Animals
2.46B
3.78%
他の
18.86B
29.02%

株主

更新時刻: 13 hours ago
更新時刻: 13 hours ago
株主統計
種類
株主統計
株主統計
比率
Vanguard Capital Management, LLC
6.52%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Investment Management (US)
4.86%
Wellington Management Company, LLP
3.50%
Vanguard Portfolio Management, LLC
2.73%
他の
76.88%
株主統計
株主統計
比率
Vanguard Capital Management, LLC
6.52%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Investment Management (US)
4.86%
Wellington Management Company, LLP
3.50%
Vanguard Portfolio Management, LLC
2.73%
他の
76.88%
種類
株主統計
比率
Investment Advisor
52.27%
Investment Advisor/Hedge Fund
27.18%
Research Firm
3.05%
Pension Fund
2.68%
Bank and Trust
2.22%
Sovereign Wealth Fund
1.63%
Hedge Fund
1.38%
Insurance Company
0.70%
Family Office
0.12%
他の
8.77%

機関投資家保有株

更新時刻: Sun, Apr 5
更新時刻: Sun, Apr 5
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q1
5687
2.01B
81.41%
-10.60M
2025Q4
5433
1.99B
80.26%
-56.89M
2025Q3
5358
2.02B
81.35%
-45.75M
2025Q2
5398
2.02B
80.82%
-16.42M
2025Q1
5446
2.05B
81.47%
-3.32M
2024Q4
5410
2.04B
80.88%
+11.87M
2024Q3
5200
2.01B
79.47%
-7.96M
2024Q2
5181
2.01B
79.28%
-4.86M
2024Q1
5154
2.00B
78.88%
-6.10M
2023Q4
5065
1.99B
78.60%
+584.81K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
136.21M
5.51%
-4.94M
-3.50%
Dec 31, 2025
State Street Investment Management (US)
120.04M
4.86%
+1.86M
+1.57%
Dec 31, 2025
Wellington Management Company, LLP
86.44M
3.5%
+11.16M
+14.82%
Dec 31, 2025
Geode Capital Management, L.L.C.
60.05M
2.43%
+249.11K
+0.42%
Dec 31, 2025
Charles Schwab Investment Management, Inc.
48.56M
1.96%
-5.14M
-9.56%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
37.98M
1.54%
+1.87M
+5.18%
Dec 31, 2025
Fidelity Management & Research Company LLC
33.75M
1.36%
+6.13M
+22.20%
Dec 31, 2025
Fisher Investments
24.87M
1.01%
+805.20K
+3.35%
Dec 31, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
VanEck Pharmaceutical ETF
16.09%
FT Vest DJIA Dogs 10 Target Income ETF
10.79%
First Trust NASDAQ Pharmaceuticals ETF
7.94%
Invesco Dow Jones Industrial Average Dividend ETF
6.94%
First Trust Morningstar Dividend Leaders Index Fund
5.39%
Coastal Compass 100 ETF
5.13%
Invesco Pharmaceuticals ETF
4.96%
VanEck Morningstar Wide Moat Value ETF
4.73%
Vaneck Durable High Dividend ETF
4.65%
Franklin Income Focus ETF
4.56%
詳細を見る
VanEck Pharmaceutical ETF
比率16.09%
FT Vest DJIA Dogs 10 Target Income ETF
比率10.79%
First Trust NASDAQ Pharmaceuticals ETF
比率7.94%
Invesco Dow Jones Industrial Average Dividend ETF
比率6.94%
First Trust Morningstar Dividend Leaders Index Fund
比率5.39%
Coastal Compass 100 ETF
比率5.13%
Invesco Pharmaceuticals ETF
比率4.96%
VanEck Morningstar Wide Moat Value ETF
比率4.73%
Vaneck Durable High Dividend ETF
比率4.65%
Franklin Income Focus ETF
比率4.56%

配当金

過去5年間の配当金総支払額は 28.91B 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Jan 27, 2026
MRK.NB Interim Cash Dividend of gross USD 0.85 paid on Apr 07, 2026 going ex on Mar 16, 2026
Mar 16, 2026
Apr 07, 2026
Mar 16, 2026
Nov 18, 2025
MRK.NB Interim Cash Dividend of gross USD 0.85 paid on Jan 08, 2026 going ex on Dec 15, 2025
Dec 15, 2025
Jan 08, 2026
Dec 15, 2025
Jul 22, 2025
MRK.NB Final Cash Dividend of gross USD 0.81 paid on Oct 07, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 07, 2025
Sep 15, 2025
May 27, 2025
MRK.NB Interim Cash Dividend of gross USD 0.81 paid on Jul 08, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jul 08, 2025
Jun 16, 2025
Jan 28, 2025
MRK.NB Interim Cash Dividend of gross USD 0.81 paid on Apr 07, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Apr 07, 2025
Mar 17, 2025
Nov 19, 2024
MRK.NB Final Cash Dividend of gross USD 0.81 paid on Jan 08, 2025 going ex on Dec 16, 2024
Dec 16, 2024
Jan 08, 2025
Dec 16, 2024
Jul 23, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Oct 07, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 07, 2024
Sep 16, 2024
May 29, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Jul 08, 2024 going ex on Jun 17, 2024
Jun 17, 2024
Jul 08, 2024
Jun 17, 2024
Jan 23, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Nov 28, 2023
MRK.NB Final Cash Dividend of gross USD 0.77 paid on Jan 08, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 08, 2024
Dec 14, 2023
詳細を見る

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI